Peer-Reviewed Journal Details
Mandatory Fields
O'Neill, S,Sweeney, J,Patterson, CC,Menzies-Gow, A,Niven, R,Mansur, AH,Bucknall, C,Chaudhuri, R,Thomson, NC,Brightling, CE,O'Neill, C,Heaney, LG,British Thoracic Soc Difficult
The cost of treating severe refractory asthma in the UK: an economic analysis from the British Thoracic Society Difficult Asthma Registry
Altmetric: 23WOS: 53 ()
Optional Fields
Severe refractory asthma poses a substantial burden in terms of healthcare costs but relatively little is known about the factors which drive these costs. This study uses data from the British Thoracic Society Difficult Asthma Registry (n=596) to estimate direct healthcare treatment costs from an National Health Service perspective and examines factors that explain variations in costs. Annual mean treatment costs among severe refractory asthma patients were 2912 pound (SD 2212) pound to mu 4217 (SD 2449) pound. Significant predictors of costs were FEV1% predicted, location of care, maintenance oral corticosteroid treatment and body mass index. Treating individuals with severe refractory asthma presents a substantial cost to the health service.
Grant Details
Publication Themes